PEB:ASX
Pacific Edge Ltd
A$0.22
0.00%
(0.00) 1D
Nov 16, 1:22:05 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Mkt. cap
348.73M
Avg. vol.
54.38K
Volume
0.00
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
Mkt. cap
348.73M
Avg. vol.
54.38K
Volume
0.00
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
News stories
From web sources and news partners
Bloomberg.com
·
1 hour ago
Wells Fargo Sees S&P 500 at 8,200 By End of 2027 as Profits Slow
marketscreener.com
·
1 hour ago
Nasdaq, S&P 500 Fall For Third Day as Nvidia Sell-Off Continues
Investing.com
·
2 hours ago
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
Traders Union
·
53 minutes ago
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd
CEO-
Employees114
Founded2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepacificedgedx.com